Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Wilhelm Woessmann, Martin Zimmermann, Andrea Meinhardt, Stephanie Müller, Holger Hauch, Fabian Knörr, Ilske Oschlies, Wolfram Klapper, Felix Niggli, Edita Kabickova, Andishe Attarbaschi, Alfred Reiter, Birgit Burkhardt

Blood (2020) 135 (14): 1124–1132.

https://doi.org/10.1182/blood.2019003591

Published: 2020

Includes: Supplemental data

Journal Articles

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Wilhelm Woessmann, MD, Martin Zimmermann, Birgit Burkhardt, Andrea Meinhardt, MD, Christine Rosenbusch, MD, Vera Vaillant, MD, Ilske Oschlies, Wolfram Klapper, MD, Felix Niggli, MD, Andishe Attarbaschi, MD, Georg Mann, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2014) 124 (21): 1738.

https://doi.org/10.1182/blood.V124.21.1738.1738

Published: 2014

Journal Articles

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

Britta Maecker-Kolhoff, MD, Rita Beier, MD, Martin Zimmermann, PhD, Brigitte Schlegelberger, MD, Ulrich Baumann, MD, Carsten Mueller, MD, Lars Pape, MD, Alfred Reiter, MD, Claudia Rossig, MD, Stephan Schubert, MD, Burkhard Toenshoff, MD, Anne-Margret Wingen, MD, Barbara Meissner, MD, Christian Kebelmann-Betzing, MD, Guenter Henze, MD, Hans H. Kreipe, MD, Christoph Klein, MD PhD

Blood (2014) 124 (21): 4468.

https://doi.org/10.1182/blood.V124.21.4468.4468

Published: 2014

Journal Articles

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Marius Rohde, Martin Zimmermann, Bettina R. Bonn, Monika Szczepanowski, Ilske Oschlies, Wolfram Klapper, MD, Anja Möricke, Martin Schrappe, Inga Nagel, Reiner Siebert, Alfred Reiter, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2980.

https://doi.org/10.1182/blood.V124.21.2980.2980

Published: 2014

Journal Articles

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Christine Damm-Welk, Lara Mussolin, Martin Zimmermann, Marta Pillon, Wolfram Klapper, Ilske Oschlies, Emanuele S. G. d’Amore, Alfred Reiter, Wilhelm Woessmann, Angelo Rosolen

Blood (2014) 123 (3): 334–337.

https://doi.org/10.1182/blood-2013-09-526202

Published: 2014

Includes: Supplemental data

Journal Articles

Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence

Bettina R. Bonn, Marius Rohde, Martin Zimmermann, David Krieger, Ilske Oschlies, Felix Niggli, Grazyna Wrobel, Andishe Attarbaschi, Gabriele Escherich, Wolfram Klapper, Alfred Reiter, Birgit Burkhardt

Blood (2013) 121 (16): 3153–3160.

https://doi.org/10.1182/blood-2012-12-474148

Published: 2013

Includes: Supplemental data

Journal Articles

Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL

Birgit Burkhardt, MD, PhD, Deniz Yavuz, Martin Zimmerman, PhD, Jutta Schieferstein, Edita Kabickova, MD, Andishe Attarbaschi, MD, Jasmin Lisfeld, MD, Bettina R. Bonn, PhD, Alfred Reiter, MD, Christine Damm-Welk, PhD

Blood (2012) 120 (21): 1547.

https://doi.org/10.1182/blood.V120.21.1547.1547

Published: 2012

Journal Articles

Major Improvement of Outcome in Pediatric High-Risk Acute Lymphoblastic Leukemia by Addition of BFM Chemotherapy Element “Phase IB”: A Comparative Data Analysis of Trials ALL-BFM 95 and ALL-BFM 2000

Anja Möricke, MD, André Schrauder, MD, Martin Zimmermann, PhD, Georg Mann, MD, Andishe Attarbaschi, MD, Rolf Koehler, PhD, Renate Panzer-Grümayer, MD, Martin Stanulla, MD, MSc, Gunnar Cario, MD, Alfred Reiter, MD, Felix Niggli, MD, Claus R Bartram, MD, Martin Schrappe, MD

Blood (2011) 118 (21): 1504.

https://doi.org/10.1182/blood.V118.21.1504.1504

Published: 2011

Journal Articles

Early Assessment of Minimal Residual Disease (MRD) by Qualitative PCR for NPM-ALK Identifies Patients At Very High Risk of Relapse in Anaplastic Large Cell Lymphoma

Christine Damm-Welk, PhD, Lara Mussolin, PhD, Marta Pillon, MD, Martin Zimmermann, PhD, Alfred Reiter, MD, Wilhelm Woessmann, MD, Angelo Rosolen, MD

Blood (2011) 118 (21): 1565.

https://doi.org/10.1182/blood.V118.21.1565.1565

Published: 2011

Journal Articles

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Blood (2011) 118 (8): 2077–2084.

https://doi.org/10.1182/blood-2011-03-338707

Published: 2011

Includes: Supplemental data

Journal Articles

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Blood (2011) 118 (1): 139–147.

https://doi.org/10.1182/blood-2011-01-330795

Published: 2011

Includes: Supplemental data

Journal Articles

Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma

Andishe Attarbaschi, Georg Mann, Angelo Rosolen, Denise Williams, Anne Uyttebroeck, Ildiko Marky, Laurence Lamant, Keizo Horibe, Grazyna Wrobel, Auke Beishuizen, Wilhelm Wössmann, Alfred Reiter, Audrey Mauguen, Marie-Cecile Le Deley, Laurence Brugières, for the European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) ALCL99 Trial

Blood (2011) 117 (21): 5616–5619.

https://doi.org/10.1182/blood-2010-12-324012

Published: 2011

Journal Articles

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Kamel Ait-Tahar, Christine Damm-Welk, Birgit Burkhardt, Martin Zimmermann, Wolfram Klapper, Alfred Reiter, Karen Pulford, Wilhelm Woessmann

Blood (2010) 115 (16): 3314–3319.

https://doi.org/10.1182/blood-2009-11-251892

Published: 2010

Includes: Supplemental data

Journal Articles

Prospective Evaluation of Thromboembolic Events During Chemotherapy of Childhood Acute Lymphoblastic Leukemia: Results of Randomized Trial ALL-BFM 2000.

Anja Möricke, MD, Martin Zimmermann, PhD, Jeanette Greiner, MD, André Schrauder, MD, Hansjörg Schmid, MD, Martin Stanulla, MD, Andishe Attarbaschi, MD, Alfred Reiter, MD, Georg Mann, MD, Martin Schrappe, MD

Blood (2009) 114 (22): 990.

https://doi.org/10.1182/blood.V114.22.990.990

Published: 2009

Journal Articles

Thiopurine Methyltransferase Genetics Is Associated with Treatment Outcome and Hepatic Toxicity in Pediatric Patients with Acute Lymphoblastic Leukemia: a Report From the ALL-BFM Study Group.

Martin Stanulla, MD, Elke Schäffeler, PhD, Silke Pohlschmidt, Martin Zimmermann, PhD, Anja Möricke, MD, Gunnar Cario, MD, Andre Schrauder, MD, Karl Welte, MD, Jochen Harbott, PhD, Wolf-Dieter Ludwig, MD, Alfred Reiter, MD, Michel Eichelbaum, MD, Martin Schrappe, MD, Matthias Schwab, MD

Blood (2009) 114 (22): 2625.

https://doi.org/10.1182/blood.V114.22.2625.2625

Published: 2009

Journal Articles

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Birgit Burkhardt, MD, PhD, Ilske Oschlies, MD, Wolfram Klapper, MD, PhD, Martin Zimmermann, PhD, Andrea Meinhardt, MD, Eva Landmann, MD, Wilhelm Woessmann, MD, PhD, Georg Mann, MD, Felix Niggli, MD, Martin Schrappe, MD, PhD, Alfred Reiter, MD, PhD

Blood (2009) 114 (22): 102.

https://doi.org/10.1182/blood.V114.22.102.102

Published: 2009

Journal Articles

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols

Martin Stanulla, Elke Schaeffeler, Anja Möricke, Sally A. Coulthard, Gunnar Cario, André Schrauder, Peter Kaatsch, Michael Dördelmann, Karl Welte, Martin Zimmermann, Alfred Reiter, Michel Eichelbaum, Hansjörg Riehm, Martin Schrappe, Matthias Schwab

Blood (2009) 114 (7): 1314–1318.

https://doi.org/10.1182/blood-2008-12-193250

Published: 2009

Journal Articles

Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma

Karen Pulford, Christine Damm-Welk, Birgit Burkhardt, Martin Zimmerman, Alfred Reiter, Kamel Ait-Tahar, Wilhelm Woessmann

Blood (2008) 112 (11): 2831.

https://doi.org/10.1182/blood.V112.11.2831.2831

Published: 2008

Journal Articles

The Impact of the Association of Vinblastine during Induction Chemotherapy and as Maintenance Treatment in Children and Adolescents with High-Risk Anaplastic Large Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group

Marie Cecile Le Deley, Angelo Rosolen, Alfred Reiter, MD, Denise Williams, MD, Keizo Horibe, MD, Grazyna Wrobel, Georg Mann, Jozsef Zsiros, Anne Uyttebroeck, Ildiko Marky, Wolfgang Klapper, Laurence Brugieres

Blood (2008) 112 (11): 577.

https://doi.org/10.1182/blood.V112.11.577.577

Published: 2008

Journal Articles

Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000)

Martin Schrappe, MD, Martin Zimmermann, PhD, Anja Möricke, MD, Georg Mann, MD, Maria Grazia Valsecchi, PhD, Claus R Bartram, MD, Andrea Biondi, MD, Renate Panzer-Grümayer, MD, André Schrauder, MD, Franco Locatelli, MD, Alfred Reiter, MD, Giuseppe Basso, MD, Felix Niggli, MD, Maurizio Aricò, MD, Valentino Conter, MD

Blood (2008) 112 (11): 7.

https://doi.org/10.1182/blood.V112.11.7.7

Published: 2008

NARROW

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence

Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL

Major Improvement of Outcome in Pediatric High-Risk Acute Lymphoblastic Leukemia by Addition of BFM Chemotherapy Element “Phase IB”: A Comparative Data Analysis of Trials ALL-BFM 95 and ALL-BFM 2000

Early Assessment of Minimal Residual Disease (MRD) by Qualitative PCR for NPM-ALK Identifies Patients At Very High Risk of Relapse in Anaplastic Large Cell Lymphoma

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Prospective Evaluation of Thromboembolic Events During Chemotherapy of Childhood Acute Lymphoblastic Leukemia: Results of Randomized Trial ALL-BFM 2000.

Thiopurine Methyltransferase Genetics Is Associated with Treatment Outcome and Hepatic Toxicity in Pediatric Patients with Acute Lymphoblastic Leukemia: a Report From the ALL-BFM Study Group.

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols

Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma

The Impact of the Association of Vinblastine during Induction Chemotherapy and as Maintenance Treatment in Children and Adolescents with High-Risk Anaplastic Large Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group

Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only